There has been a great deal of scientific research on the therapeutic aspects of PCOS/hirsutism/acne, which has intensified more recently. A PubMed search on “Treatment of polycystic ovary syndrome” returned 3580 items published in the 51 years comprised between 1957 and March 04, 2008; of these, 607 (17%) were in the 2 years, between Jan 01, 2006 and March 04, 2008. A PubMed search on “Treatment of hirsutism” returned 2211 items published in the 57 years comprised between 1951 and March 04, 2008; of these, 192 (9%) were in the 2 years between Jan 01, 2006 and March 04, 2008. At the recent 13th World Congress on Gynecological Endocrinology (Florence, February 28-March 02, 2008), 15 oral presentations and 3 posters focused on treatment of PCOS.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Kiddy DS, Hamilton-Fairley D, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992; 36:105–11
Koulouri O, Conway GS. A systematic review of commonly used medical treatments for hirsutism in women. Clin Endocrinol (Oxf). 2008 Feb 14 [Epub ahead of print]
Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008; 23: 462–77
Sonino N, Fava GA, Mani E et al. Quality of life of irsute women. Postgrad Med J 1993; 69:186–189
Shapiro J, Lui H. Vaniqa – eflornithine 13.9% cream. Skin Therapy Lett 2001; 6:1–3
http://emc.medicines.org.uk/emc/assets/c/html/DisplayDoc.asp?DocumentID=14852 (accessed March 04, 2008)
Califano L, Cannavò S, Siragusa M, et al. Experience in the therapy of acne with topical administration of spironolactone as an antiandrogen. Clin Ter 1990; 15;135:193–99
Berardesca E, Gabba P, Ucci G, et al. Topical spironolactone inhibits dihydrotestosterone receptors in human sebaceous glands: an autoradiographic study in subjects with acne vulgaris. Int J Tissue React 1988; 10:115–19.
Richards RN, Uy M, Meharg G. Temporary hair removal in patients with hirsutism: a clinical study. Cutis 1990; 45: 199–202.
(http://www.fda.gov/cdrh/consumer/laserfacts.html updated February 28, 2008) (accessed, March 04, 2008)
Haedersdal M, Wulf HC. Evidence-based review of hair removal using lasers and light sources. J Eur Acad Dermatol Venereol 2006; 20: 9–20
Sadighha A, Mohaghegh Zahed G. Meta-analysis of hair removal laser trials. Lasers Med Sci 2007 Nov 20 [Epub ahead of print]
Loo WJ, Lanigan SW. Laser treatment improves quality of life of hirsute females. Clin Exp Dermatol 2002; 27 :439–41
Clayton WJ, Lipton M, Elford J, et al. A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Br J Dermatol 2005; 152: 986–92
Conroy FJ, Venus M, Monk B. A qualitative study to assess the effectiveness of laser epilation using a qualify-of-life scoring system. Clin Exp Dermatol 2006; 31:753–56
Hamzavi I, Tan E, Shapiro J, et al. A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women. J Am Acad Dermatol 2007; 57:54–9.
Meyer C, McGrath BP, Teede HJ. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care 2007; 30: 471–78
http://www.notmypill.org/ (accessed March 04, 2008)
Elter K, Imir G, Durmusoglu F. Clinical endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovary syndrome: a randomized controlled study. Human Reprod 2002; 17: 1729–37
Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI, et al. Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2007; 92:2453–61
De Leo V, Fulghesu AM, La Marca A et al. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism. Gynecol Endocrinol. 2000; 14:411–16
Carmina E, Lobo RA. A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women. Clin Endocrinol (Oxf) 2002; 57:231–34.
Swiglo BA, Cosma M, Flynn DN, et al. Clinical review: Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab. 2008 Apr;93(4):1153–60. Epub 2008 Feb 5.
Ibáñez L, Jaramillo A, Ferrer A, et al. Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women. Hum Reprod 2005; 20:1833–36.
Ibáñez L, Ong K, Ferrer A, et al. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism. J Clin Endocrinol Metab 2003; 88:2600–06.
Ibáñez L, López-Bermejo A, del Rio L, et al. Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess. J Clin Endocrinol Metab 2007; 92:1710–14.
Venturoli S, Marescalchi O, Colombo FM, et al. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism J Clin Endocrinol Metab 1999; 84:1304–10
Moghetti P, Tosi F, Tosti A, et al. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial. J Clin Endocrinol Metab 2000; 85:89–94
Müderris II, Bayram F, Güven M. prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism. Fertil Steril 2000; 73:984–87
Farquhar C, Lee O Toomath R, et al. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne Cochrane database Syst Rev 2003; 4:CD000194
Van der Spuy ZM, le Roux PA. Cyproterone acetate for hirsutism. Cochrane database Syst Rev 2003; 4:CD001125
Gambineri A, Patton L, Vaccina A, et al. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study J Clin Endocrinol 2006; 91:3970–80
Calaf J, Lopez E, Millet A, et al. Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial. J Clin Endocrinol Metab 2007; 92:3446–52
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Benvenga, S. (2009). Therapy of Hirsutism. In: Farid, N.R., Diamanti-Kandarakis, E. (eds) Diagnosis and Management of Polycystic Ovary Syndrome. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-09718-3_19
Download citation
DOI: https://doi.org/10.1007/978-0-387-09718-3_19
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-09717-6
Online ISBN: 978-0-387-09718-3
eBook Packages: MedicineMedicine (R0)